Akber A, Portale AA, Johansen KL Pedometer-assessed physical activity in children and young adults with CKD. Clin J Am Soc Nephrol. 2012 May;7(5):720-6. doi: 10.2215/CJN.06330611. Epub 2012 Mar 15.
Beddhu S, Baird BC, Zitterkoph J, Neilson J, Greene T Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009 Dec;4(12):1901-6. doi: 10.2215/CJN.01970309. Epub 2009 Oct 9.
Beddhu S, Wei G, Marcus RL, Chonchol M, Greene T Light-intensity physical activities and mortality in the United States general population and CKD subpopulation. Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1145-53. doi: 10.2215/CJN.08410814. Epub 2015 Apr 30.
Benzo RP, Sciurba FC Oxygen consumption, shuttle walking test and the evaluation of lung resection. Respiration. 2010;80(1):19-23. doi: 10.1159/000235543. Epub 2009 Aug 11.
Dowd KP, Harrington DM, Donnelly AE Criterion and concurrent validity of the activPAL™ professional physical activity monitor in adolescent females. PLoS One. 2012;7(10):e47633. doi: 10.1371/journal.pone.0047633. Epub 2012 Oct 19.
Freak-Poli R, Wolfe R, Peeters A Risk of cardiovascular disease and diabetes in a working population with sedentary occupations. J Occup Environ Med. 2010 Nov;52(11):1132-7. doi: 10.1097/JOM.0b013e3181f8da77.
Freedson PS, Lyden K, Kozey-Keadle S, Staudenmayer J Evaluation of artificial neural network algorithms for predicting METs and activity type from accelerometer data: validation on an independent sample. J Appl Physiol (1985). 2011 Dec;111(6):1804-12. doi: 10.1152/japplphysiol.00309.2011. Epub 2011 Sep 1.
Greenberg AS, Obin MS Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006 Feb;83(2):461S-465S. Review.
Hamilton MT, Hamilton DG, Zderic TW Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes. 2007 Nov;56(11):2655-67. Epub 2007 Sep 7. Review.
Harrington DM, Welk GJ, Donnelly AE Validation of MET estimates and step measurement using the ActivPAL physical activity logger. J Sports Sci. 2011 Mar;29(6):627-33. doi: 10.1080/02640414.2010.549499.
Heiwe S, Jacobson SH Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD003236. doi: 10.1002/14651858.CD003236.pub2. Review.
Hu FB, Li TY, Colditz GA, Willett WC, Manson JE Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003 Apr 9;289(14):1785-91.
Hu FB Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids. 2003 Feb;38(2):103-8. Review.
Kozey-Keadle S, Libertine A, Staudenmayer J, Freedson P The Feasibility of Reducing and Measuring Sedentary Time among Overweight, Non-Exercising Office Workers. J Obes. 2012;2012:282303. doi: 10.1155/2012/282303. Epub 2011 Nov 16.
Levine JA, Eberhardt NL, Jensen MD Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science. 1999 Jan 8;283(5399):212-4.
Lyden K, Keadle SK, Staudenmayer J, Freedson PS A method to estimate free-living active and sedentary behavior from an accelerometer. Med Sci Sports Exerc. 2014 Feb;46(2):386-97. doi: 10.1249/MSS.0b013e3182a42a2d.
Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol. 2011 Dec;43(4):1133-41. doi: 10.1007/s11255-010-9823-7. Epub 2010 Sep 15.
Otten JJ, Jones KE, Littenberg B, Harvey-Berino J Effects of television viewing reduction on energy intake and expenditure in overweight and obese adults: a randomized controlled trial. Arch Intern Med. 2009 Dec 14;169(22):2109-15. doi: 10.1001/archinternmed.2009.430.
Owen N, Healy GN, Matthews CE, Dunstan DW Too much sitting: the population health science of sedentary behavior. Exerc Sport Sci Rev. 2010 Jul;38(3):105-13. doi: 10.1097/JES.0b013e3181e373a2.
Pinto Pereira SM, Ki M, Power C Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work. PLoS One. 2012;7(2):e31132. doi: 10.1371/journal.pone.0031132. Epub 2012 Feb 9.
Ryan CG, Grant PM, Tigbe WW, Granat MH The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med. 2006 Sep;40(9):779-84. Epub 2006 Jul 6.
Sietsema KE, Amato A, Adler SG, Brass EP Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int. 2004 Feb;65(2):719-24.
Solomon TP, Thyfault JP Type 2 diabetes sits in a chair. Diabetes Obes Metab. 2013 Nov;15(11):987-92. doi: 10.1111/dom.12105. Epub 2013 Apr 22. Review.
Thorp AA, Owen N, Neuhaus M, Dunstan DW Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med. 2011 Aug;41(2):207-15. doi: 10.1016/j.amepre.2011.05.004. Review.
Tucker JM, Welk GJ, Beyler NK Physical activity in U.S.: adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med. 2011 Apr;40(4):454-61. doi: 10.1016/j.amepre.2010.12.016.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.